Journal of Pediatrics Review

Published by: Kowsar

Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature

Javad Ghaffari 1 , * , Soheila Shahmohammadi 1 , Hossein Ashrafi 2 , Ali Reza Ranjbar 3 and Negar Ghaffari 4
Authors Information
1 Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Beatson Institute for Cancer Research, Faculty of Medicine, University of Glasgow, Glasgow, UK
3 Research Institute of Interventional Allergology and Immunology, Bonn, Germany
4 Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: January 30, 2015, 3 (1); e152
  • Published Online: January 15, 2015
  • Article Type: Review Article
  • Received: April 3, 2014
  • Revised: June 10, 2014
  • Accepted: July 3, 2014
  • DOI: 10.5812/jpr.152

To Cite: Ghaffari J, Shahmohammadi S, Ashrafi H, Ranjbar A R, Ghaffari N. et al. Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature, J Pediatr Rev. 2015 ;3(1):e152. doi: 10.5812/jpr.152.

Abstract
Copyright: Copyright © 0, Journal of Pediatrics Review. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. Ghaffari J. Acute chronic urticarial: review of etiology, pathogenesis, manifestation and treatment. J Clin Excell. 2013; 1(1): 83-102
  • 2. Ghaffari J, Farid Hossaini R, Rafatpanah H, Jabbari Azad F, Shahmohammadi S. Chronic urticaria in children: Etiologies, Clinical Manifestations, Diagnosis and Treatment. J Pediatr Rev. 2013; 1(2): 55-68
  • 3. Du Toit G, Prescott R, Lawrence P, Johar A, Brown G, Weinberg EG, et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol. 2006; 96(2): 341-4[DOI][PubMed]
  • 4. Ghosh S, Kanwar AJ, Kaur S. Urticaria in children. Pediatr Dermatol. 1993; 10(2): 107-10[PubMed]
  • 5. Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G. The etiology of different forms of urticaria in childhood. Pediatr Dermatol. 2004; 21(2): 102-8[DOI][PubMed]
  • 6. Kauppinen K, Juntunen K, Lanki H. Urticaria in children. Retrospective evaluation and follow-up. Allergy. 1984; 39(6): 469-72[PubMed]
  • 7. Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taieb A. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol. 1998; 134(3): 319-23[PubMed]
  • 8. Bretag AH, Archer RS, Atkinson HM, Woods WH. Circadian urticaria: another campylobacter association. Lancet. 1984; 1(8383): 954[PubMed]
  • 9. Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol. 1996; 34(4): 685-6[PubMed]
  • 10. Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. 1998; 78(6): 440-2[PubMed]
  • 11. Ehlers I, Niggemann B, Binder C, Zuberbier T. Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy. 1998; 53(11): 1074-7[PubMed]
  • 12. Hesselmar B, Eriksson B, Aberg N. Urticaria is associated with birch-pollen sensitization. Pediatr Allergy Immunol. 2007; 18(8): 692-5[DOI][PubMed]
  • 13. Ghaffari J, Mohammadzadeh I, Mahdavi MR. Skin Prick Test with Aeroallergens in Patients with Chronic Urticaria. J Babol Univ Med Sci. 2012; 14(2): 66-72
  • 14. Dalal I, Levine A, Somekh E, Mizrahi A, Hanukoglu A. Chronic urticaria in children: expanding the "autoimmune kaleidoscope". Pediatrics. 2000; 106(5): 1139-41[PubMed]
  • 15. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004; 114(3): 465-74[DOI][PubMed]
  • 16. Levine A, Dalal I, Bujanover Y. Celiac disease associated with familial chronic urticaria and thyroid autoimmunity in a child. Pediatrics. 1999; 104(2)[PubMed]
  • 17. Dreyfus DH, Schocket AL, Milgrom H. Steroid-resistant chronic urticaria associated with anti-thyroid microsomal antibodies in a nine-year-old boy. J Pediatr. 1996; 128(4): 576-8[PubMed]
  • 18. Metz M, Maurer M. Omalizumab in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012; 12(4): 406-11[DOI][PubMed]
  • 19. Staubach P, Vonend A, Burow G, Metz M, Magerl M, Maurer M. Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses. 2009; 52(4): 334-8[DOI][PubMed]
  • 20. Horio T, Minami K. Solar uticaria. Photoallergen in a patient's serum. Arch Dermatol. 1977; 113(2): 157-60[PubMed]
  • 21. Murphy GM, Greaves MW, Zollman PE, Winkelmann RK. Cholinergic urticaria, passive transfer experiments from human to monkey. Dermatologica. 1988; 177(6): 338-40[PubMed]
  • 22. Murphy GM, Zollman PE, Greaves MW, Winkelmann RK. Symptomatic dermographism (factitious urticaria)--passive transfer experiments from human to monkey. Br J Dermatol. 1987; 116(6): 801-4[PubMed]
  • 23. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011; 6(4)[DOI][PubMed]
  • 24. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007; 37(5): 631-50[DOI][PubMed]
  • 25. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006; 61(3): 316-20[DOI][PubMed]
  • 26. Ghaffari J. Leserbriefe. J Dtsch Dermatol Ges. 2014; 12(4): 365[DOI][PubMed]
  • 27. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau AM, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009; 64(10): 1427-43[DOI][PubMed]
  • 28. Robinson PD, Waters K. Are children just small adults? The differences between paediatric and adult sleep medicine. Intern Med J. 2008; 38(9): 719-31[DOI][PubMed]
  • 29. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998; 138(1): 101-6[PubMed]
  • 30. Zitelli KB, Cordoro KM. Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol. 2011; 28(6): 629-39[DOI][PubMed]
  • 31. Greaves MW. Chronic urticaria in childhood. Allergy. 2000; 55(4): 309-20[PubMed]
  • 32. Giuliodori K, Ganzetti G, Campanati A, Simonetti O, Marconi B, Offidani A. A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin. J Eur Acad Dermatol Venereol. 2009; 23(5): 619-20[DOI][PubMed]
  • 33. Doshi DR, Weinberger MM. Experience with cyclosporine in children with chronic idiopathic urticaria. Pediatr Dermatol. 2009; 26(4): 409-13[DOI][PubMed]
  • 34. Viegas LP, Ferreira MB, Kaplan AP. The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014; 24(1): 1-5[PubMed]
  • 35. Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol. 2007; 99(2): 190-3[DOI][PubMed]
  • 36. Vichyanond P. Omalizumab in allergic diseases, a recent review. Asian Pac J Allergy Immunol. 2011; 29(3): 209-19[PubMed]
  • 37. Ishizaka K, Ishizaka T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol. 1967; 99(6): 1187-98[PubMed]
  • 38. Viswanathan RK, Moss MH, Mathur SK. Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria. Allergy Asthma Proc. 2013; 34(5): 446-52[DOI][PubMed]
  • 39. Kopp MV. Omalizumab: Anti-IgE therapy in allergy. Curr Allergy Asthma Rep. 2011; 11(2): 101-6[DOI][PubMed]
  • 40. Kessel A, Helou W, Bamberger E, Sabo E, Nusem D, Panassof J, et al. Elevated serum total IgE--a potential marker for severe chronic urticaria. Int Arch Allergy Immunol. 2010; 153(3): 288-93[DOI][PubMed]
  • 41. Kawakami T, Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol. 2005; 175(7): 4167-73[PubMed]
  • 42. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011; 128(3): 567-73 e1[DOI][PubMed]
  • 43. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006; 117(6): 1415-8[DOI][PubMed]
  • 44. Groffik A, Mitzel-Kaoukhov H, Magerl M, Maurer M, Staubach P. Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy. 2011; 66(2): 303-5[DOI][PubMed]
  • 45. Al-Ahmad M. Omalizumab therapy in three patients with chronic autoimmune urticaria. Ann Saudi Med. 2010; 30(6): 478-81[PubMed]
  • 46. Magerl M, Staubach P, Altrichter S, Ardelean E, Krause K, Metz M, et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol. 2010; 126(3): 665-6[DOI][PubMed]
  • 47. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008; 122(3): 569-73[DOI][PubMed]
  • 48. Rodriguez-Trabado A, Fernandez Pereira LM, Romero-Chala S, Garcia-Trujillo JA, Camara Hijon C. Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test. Allergol Immunopathol (Madr). 2012; 40(6): 390-2[DOI][PubMed]
  • 49. Sanchez-Machin I, Iglesias-Souto J, Franco A, Barrios Y, Gonzalez R, Matheu V. T cell activity in successful treatment of chronic urticaria with omalizumab. Clin Mol Allergy. 2011; 9: 11[DOI][PubMed]
  • 50. Saavedra MC, Sur S. Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy. 2011; 9(1): 2[DOI][PubMed]
  • 51. Korkmaz H, Eigelshoven S, Homey B. [Omalizumab for therapy-resistant chronic urticaria with angioedema]. Hautarzt. 2010; 61(10): 828-31[DOI][PubMed]
  • 52. Bailey E, Shaker M. An update on childhood urticaria and angioedema. Curr Opin Pediatr. 2008; 20(4): 425-30[DOI][PubMed]
  • 53. Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013; 368(10): 924-35[DOI][PubMed]
  • 54. Uysal P, Eller E, Mortz CG, Bindslev-Jensen C. An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized. J Allergy Clin Immunol. 2014; 133(3): 914-5 e2[DOI][PubMed]
  • 55. Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy. 2010; 65(1): 138-9[DOI][PubMed]
  • 56. Altman MC, Naimi DR. Omalizumab for chronic urticaria. N Engl J Med. 2013; 368(26): 2528-30[DOI][PubMed]
  • 57. Ghaffari J, Farid Hossaini R, Rafatpanah H, Jabbari Azad F, Shahmohammadi S. Chronic urticaria in children: Etiologies, Clinical Manifestations, Diagnosis and Treatment. Journal of Pediatrics Review. 2013; 1(2): 55-68
  • 58. Asero R, Casalone R, Iemoli E. Extraordinary response to omalizumab in a child with severe chronic urticaria. Eur Ann Allergy Clin Immunol. 2014; 46(1): 41-2[PubMed]
  • 59. Pite H, Wedi B, Borrego LM, Kapp A, Raap U. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013; 93(5): 500-8[DOI][PubMed]
  • 60. Jurakic Toncic R, Lipozencic J, Marinovic B. Treatment of chronic urticaria. Acta Dermatovenerol Croat. 2009; 17(4): 305-22[PubMed]
  • 61. Sanchez J, Ramirez R, Diez S, Sus S, Echenique A, Olivares M, et al. Omalizumab beyond asthma. Allergol Immunopathol (Madr). 2012; 40(5): 306-15[DOI][PubMed]
  • 62. Marrouche N, Grattan C. Childhood urticaria. Curr Opin Allergy Clin Immunol. 2012; 12(5): 485-90[DOI][PubMed]
  • 63. Asero R, Tedeschi A, Cugno M. Treatment of refractory chronic urticaria: current and future therapeutic options. Am J Clin Dermatol. 2013; 14(6): 481-8[DOI][PubMed]
  • 64. Godse KV. Omalizumab in severe chronic urticaria. Indian J Dermatol Venereol Leprol. 2008; 74(2): 157-8[PubMed]
  • 65. Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013; 132(1): 101-9[DOI][PubMed]
  • 66. Davydov L. Omalizumab (Xolair) for treatment of asthma. Am Fam Physician. 2005; 71(2): 341-2[PubMed]
  • 67. Baena-Cagnani CE, Gomez RM. Current status of therapy with omalizumab in children. Curr Opin Allergy Clin Immunol. 2014; 14(2): 149-54[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader